Related Experiment Video
Updated: Mar 12, 2026

05:12
Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
Published on: September 4, 2017
11.4K
Heterozygous MTHFR A1298C Mutation causing Cerebral Venous Sinus Thrombosis
Jimil H Shah1, Kaustubh D Salagre2, Ravindra Nath Sahay3
1Post Graduate student in General Medicine.
The Journal of the Association of Physicians of India
|November 3, 2016
Summary
A young adult experienced generalized tonic-clonic seizures due to cerebral venous sinus thrombosis. This condition was linked to a heterozygous methylenetetrahydrofolate reductase (MTHFR) A1298C mutation, highlighting a genetic link to thrombosis.
Area of Science:
- Neurology
- Genetics
- Vascular Medicine
Background:
- Cerebral venous sinus thrombosis (CVST) is a rare but serious condition that can lead to seizures and neurological deficits.
- Generalized tonic-clonic seizures are a common presentation of neurological compromise.
- Identifying the underlying cause of CVST is crucial for effective management and prevention of recurrence.
Observation:
- A 21-year-old college student presented with a history of generalized tonic-clonic seizures.
- MR Venography identified left sigmoid and transverse sinus thrombosis.
- Secondary venous hemorrhagic infarcts were observed in the affected areas.
Findings:
- Thorough investigation revealed a heterozygous methylenetetrahydrofolate reductase (MTHFR) A1298C mutation in the patient.
- This specific MTHFR gene variant was identified as the causative factor for the cerebral venous sinus thrombosis.
- The mutation likely impairs folate metabolism, contributing to a prothrombotic state.
Implications:
- This case underscores the importance of genetic screening, specifically for MTHFR mutations, in young individuals presenting with unexplained cerebral venous sinus thrombosis.
- Early diagnosis of MTHFR A1298C mutation can guide personalized treatment strategies, including anticoagulation and potentially folate supplementation.
- Understanding the genetic underpinnings of CVST can improve patient outcomes and inform future research into thrombophilia.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
83
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
83
Venous Thrombosis I: Introduction
618
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
618
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
418
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
418
Genetic Lingo
116.6K
Overview
116.6K
